Published

AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of managed care & specialty pharmacy
Date: 2026-09-01
Source: Europe PMC
DOI: 10.18553/jmcp.2026.32.9-a.s1
PubMed: 42658027

Authors

Flavin B Small G Dragovich C Haumschild R Richardson T Shannon MH.

Watch author

Derived topics and classifications

psilocybin Depression Treatment-Resistant Depression Qualitative Study

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health TreatmentThe journal of desk research review and analysis. · 2025-12-16 Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-19 Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials.Drug testing and analysis · 2020-10-01 Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug testing and analysis · 2022-08-01 Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.Drug testing and analysis · 2022-07-01 Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis.Drug testing and analysis · 2021-02-01 Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushroomsJournal of Pharmaceutical and Biomedical Analysis · 2020-10-01 DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocinJournal of Pharmaceutical and Biomedical Analysis · 2016-06-01